Insufficient scRNA-seq data for expression of FFAR3 at single-cell level.
Insufficient scRNA-seq data for expression of FFAR3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adipose | 92% | 61.40 | 1103 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 146.79 | 751 / 929 | 0% | 0 | 0 / 0 |
breast | 80% | 46.10 | 368 / 459 | 0% | 0.00 | 1 / 1118 |
spleen | 77% | 26.57 | 185 / 241 | 0% | 0 | 0 / 0 |
intestine | 72% | 15.75 | 692 / 966 | 1% | 0.02 | 7 / 527 |
thymus | 60% | 12.40 | 392 / 653 | 0% | 0.01 | 2 / 605 |
lung | 47% | 7.77 | 269 / 578 | 0% | 0.00 | 3 / 1155 |
stomach | 45% | 5.53 | 162 / 359 | 0% | 0.00 | 1 / 286 |
eye | 0% | 0 | 0 / 0 | 43% | 1.49 | 34 / 80 |
pancreas | 32% | 3.21 | 106 / 328 | 6% | 0.10 | 11 / 178 |
prostate | 34% | 4.64 | 83 / 245 | 0% | 0 | 0 / 502 |
ovary | 31% | 3.57 | 55 / 180 | 1% | 0.01 | 5 / 430 |
bladder | 29% | 4.76 | 6 / 21 | 1% | 0.01 | 5 / 504 |
blood vessel | 26% | 6.16 | 344 / 1335 | 0% | 0 | 0 / 0 |
brain | 25% | 2.95 | 662 / 2642 | 0% | 0.00 | 2 / 705 |
heart | 20% | 2.76 | 171 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 10% | 1.01 | 27 / 258 | 7% | 0.15 | 15 / 230 |
liver | 14% | 1.91 | 31 / 226 | 1% | 0.01 | 4 / 406 |
esophagus | 12% | 1.14 | 177 / 1445 | 1% | 0.01 | 1 / 183 |
uterus | 11% | 0.99 | 18 / 170 | 0% | 0.01 | 1 / 459 |
kidney | 9% | 1.03 | 8 / 89 | 1% | 0.01 | 6 / 901 |
skin | 6% | 0.62 | 108 / 1809 | 1% | 0.02 | 5 / 472 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.14 | 2 / 29 |
muscle | 3% | 0.27 | 22 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0014061 | Biological process | regulation of norepinephrine secretion |
GO_0071398 | Biological process | cellular response to fatty acid |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_0046626 | Biological process | regulation of insulin receptor signaling pathway |
GO_0046885 | Biological process | regulation of hormone biosynthetic process |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0045776 | Biological process | negative regulation of blood pressure |
GO_0006954 | Biological process | inflammatory response |
GO_0002879 | Biological process | positive regulation of acute inflammatory response to non-antigenic stimulus |
GO_0007193 | Biological process | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO_0002385 | Biological process | mucosal immune response |
GO_0090276 | Biological process | regulation of peptide hormone secretion |
GO_0002720 | Biological process | positive regulation of cytokine production involved in immune response |
GO_0005886 | Cellular component | plasma membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0008289 | Molecular function | lipid binding |
Gene name | FFAR3 |
Protein name | Free fatty acid receptor 3 (G-protein coupled receptor 41) Free fatty acid receptor 3 (G-protein coupled receptor) G-protein coupled receptor |
Synonyms | GPR41 |
Description | FUNCTION: G protein-coupled receptor that is activated by a major product of dietary fiber digestion, the short chain fatty acids (SCFAs), and that plays a role in the regulation of whole-body energy homeostasis and in intestinal immunity. In omnivorous mammals, the short chain fatty acids acetate, propionate and butyrate are produced primarily by the gut microbiome that metabolizes dietary fibers. SCFAs serve as a source of energy but also act as signaling molecules. That G protein-coupled receptor is probably coupled to the pertussis toxin-sensitive, G(i/o)-alpha family of G proteins. Its activation results in the formation of inositol 1,4,5-trisphosphate, the mobilization of intracellular calcium, the phosphorylation of the MAPK3/ERK1 and MAPK1/ERK2 kinases and the inhibition of intracellular cAMP accumulation . Activated by SCFAs and by beta-hydroxybutyrate, a ketone body produced by the liver upon starvation, it inhibits N-type calcium channels and modulates the activity of sympathetic neurons through a signaling cascade involving the beta and gamma subunits of its coupled G protein, phospholipase C and MAP kinases. Thereby, it may regulate energy expenditure through the control of the sympathetic nervous system that controls for instance heart rate. Upon activation by SCFAs accumulating in the intestine, it may also signal to the brain via neural circuits which in turn would regulate intestinal gluconeogenesis. May also control the production of hormones involved in whole-body energy homeostasis. May for instance, regulate blood pressure through renin secretion. May also regulate secretion of the PYY peptide by enteroendocrine cells and control gut motility, intestinal transit rate, and the harvesting of energy from SCFAs produced by gut microbiota. May also indirectly regulate the production of LEP/Leptin, a hormone acting on the CNS to inhibit food intake, in response to the presence of short-chain fatty acids in the intestine. Finally, may also play a role in glucose homeostasis. Besides its role in energy homeostasis, may play a role in intestinal immunity. May mediate the activation of the inflammatory and immune response by SCFAs in the gut, regulating the rapid production of chemokines and cytokines by intestinal epithelial cells. Among SCFAs, the fatty acids containing less than 6 carbons, the most potent activators are probably propionate, butyrate and pentanoate while acetate is a poor activator . . |
Accessions | ENST00000327809.5 A0A0K0PV71 A0A0K0PUW4 A0A0K0PW26 A0A0K0PV66 A0A0K0PUW7 A0A0K0PUW9 A0A0K0PUV2 B0M0K0 A0A0K0PUX8 A0A0K0PUV6 O14843 ENST00000594310.1 |